
Seasoned biotech professional with extensive experience leading cell therapies and biologics from conception to the clinic.
Aligning academic innovation with commercial and corporate strategy
Strategic nonclinical IND support spanning study design, CRO oversight, and regulatory-ready documentation to ensure submission confidence.
Ongoing oversight of post-IND nonclinical studies, with hands-on CRO management and clear, regulatory-ready reporting to support program continuity and lifecycle decisions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.